Insulin Efsitora Alfa
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Insulin Efsitora Alfa, covering 2025-04-27 to 2025-08-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) [Phase 3]